These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39014101)

  • 21. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
    Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining an approach for therapeutic strategies in metabolic dysfunction-associated steatotic liver disease after liver transplantation.
    Siddiqui MS; Muthiah M; Satapathy SK; Patidar KR; Bhat M; Brandman D; Watt KD; Rinella M
    Hepatology; 2023 Dec; ():. PubMed ID: 38088872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant Recipients.
    Levitsky J; Goldberg D; Smith AR; Mansfield SA; Gillespie BW; Merion RM; Lok AS; Levy G; Kulik L; Abecassis M; Shaked A
    Clin Gastroenterol Hepatol; 2017 Apr; 15(4):584-593.e2. PubMed ID: 27567694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
    Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
    Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging Issue.
    Savino A; Loglio A; Neri F; Camagni S; Pasulo L; Lucà MG; Trevisan R; Fagiuoli S; Viganò M
    J Clin Med; 2024 Jun; 13(13):. PubMed ID: 38999436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
    Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
    Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
    Wong RJ; Ahmed A
    Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional status of heart transplant recipients predicts survival.
    Shaw TB; Blitzer D; Carter KT; Lirette S; Mohammed A; Copeland J; Baran DA; Copeland H
    Clin Transplant; 2022 Aug; 36(8):e14748. PubMed ID: 35723881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alcohol Use after Liver Transplantation is Independent of Liver Disease Etiology.
    Russ KB; Chen NW; Kamath PS; Shah VH; Kuo YF; Singal AK
    Alcohol Alcohol; 2016 Nov; 51(6):698-701. PubMed ID: 27267907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Underestimation of Liver Transplantation for Alcoholic Hepatitis in the National Transplant Database.
    Lee BP; Im GY; Rice JP; Weinberg E; Hsu C; Fix OK; Therapondos G; Han H; Victor DW; Eswaran S; Maddur H; Terrault NA
    Liver Transpl; 2019 May; 25(5):706-711. PubMed ID: 30882995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-transplant Outcomes of Persons Receiving a Liver Graft for Alcoholic Liver Disease.
    Rogal S; Shenai N; Kruckenberg K; Rosenberger E; Dew MA; DiMartini A
    Alcohol Alcohol; 2018 Mar; 53(2):157-165. PubMed ID: 29293880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent trends in liver transplantation for alcoholic liver disease in the United States.
    Kling CE; Perkins JD; Carithers RL; Donovan DM; Sibulesky L
    World J Hepatol; 2017 Dec; 9(36):1315-1321. PubMed ID: 29359014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
    Younossi Z; Stepanova M; Ong JP; Jacobson IM; Bugianesi E; Duseja A; Eguchi Y; Wong VW; Negro F; Yilmaz Y; Romero-Gomez M; George J; Ahmed A; Wong R; Younossi I; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):748-755.e3. PubMed ID: 29908364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
    Sayiner M; Stepanova M; De Avila L; Golabi P; Racila A; Younossi ZM
    Dig Dis Sci; 2020 Feb; 65(2):416-422. PubMed ID: 31451982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
    Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list.
    Chhatwal J; Samur S; Kues B; Ayer T; Roberts MS; Kanwal F; Hur C; Donnell DM; Chung RT
    Hepatology; 2017 Mar; 65(3):777-788. PubMed ID: 27906468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Outcomes of Simultaneous Liver-Kidney Transplant Patients with Hepatitis B Compared to with Liver Transplant Alone.
    Li H; Fan MQ; Men TY; Wang YP; Xing TH; Fan JW; Peng ZH; Zhong L
    Med Sci Monit; 2016 Feb; 22():332-40. PubMed ID: 26828767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of recipient and donor gender-match and mismatch on the post-liver transplant outcomes of patients with primary biliary cholangitis.
    Lee DU; Ponder R; Sandlow S; Yoo A; Lee KJ; Chou H; Fan GH; Urrunaga NH
    Dig Liver Dis; 2023 Sep; 55(9):1242-1252. PubMed ID: 37085440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic liver disease after allogeneic hematopoietic cell transplantation.
    Randhawa B; Blosser N; Daly A; Storek J; Shaheen AA; Jamani K
    Cytotherapy; 2024 Jul; ():. PubMed ID: 39046389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
    Lewin SM; Mehta N; Kelley RK; Roberts JP; Yao FY; Brandman D
    Liver Transpl; 2017 Aug; 23(8):1015-1022. PubMed ID: 28340509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.